Edition:
United Kingdom

Evolent Health Inc (EVH.N)

EVH.N on New York Stock Exchange

14.55USD
6:19pm GMT
Change (% chg)

$0.35 (+2.46%)
Prev Close
$14.20
Open
$14.25
Day's High
$14.55
Day's Low
$14.25
Volume
24,663
Avg. Vol
251,395
52-wk High
$27.50
52-wk Low
$10.30

Select another date:

Wed, Jan 10 2018

BRIEF-Evolent Health Sees Adjusted Services Revenue Growth In Mid-To-High Teens For 2018‍​

* EVOLENT HEALTH SAYS ANTICIPATES MEETING OR EXCEEDING ISSUED ADJUSTED REVENUE, ADJUSTED EBITDA GUIDANCE FOR THREE MONTHS ENDED DEC 31, 2017 - SEC FILING

BRIEF-Evolent Health And Premier Health Terminate Agreement For Acquisition Of Premier Health Plan

* EVOLENT HEALTH AND PREMIER HEALTH ANNOUNCE TERMINATION OF AGREEMENT FOR ACQUISITION OF PREMIER HEALTH PLAN

BRIEF-Evolent Health announces third quarter 2017 results

* Q3 revenue $107.9 million versus I/B/E/S view $104.5 million

BRIEF-Evolent Health ‍signed expanded relationship agreement with Premier Health​

* Evolent Health Inc - ‍signed an expanded relationship agreement with long-standing customer, Premier Health​

BRIEF-Jpmorgan Chase & Co reports 10 pct passive stake in Evolent Health Inc as of Sept. 29

* Jpmorgan chase & co reports 10 percent passive stake in Evolent Health Inc as of September 29, 2017 - SEC filing Source text for Eikon: Further company coverage:

BRIEF-Evolent Health announces proposed expansion of relationships in Illinois and New Mexico

* Evolent Health announces proposed expansion of relationships in Illinois and New Mexico

BRIEF-Evolent health prices public offering of 8.8 mln class A shares at $19.85 per share

* Evolent Health announces pricing of public offering of class a common stock

BRIEF-Evolent Health files for potential stock shelf size not disclosed - SEC filing

* Files for potential stock shelf; size not disclosed - SEC filing

BRIEF-Evolent Health Inc says launch of a proposed public offering of $175 mln of its class A common stock

* Evolent Health Inc announces proposed public offering of class A common stock

BRIEF-Evolent Health Q2 loss per share $‍0.28​

* Q2 revenue $107.1 million versus I/B/E/S view $104.5 million

Select another date: